News

Edurant, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is used as part of a highly active antiretroviral therapy (HAART) regimen that is designed to suppress the amount of HIV

China Ruitai’s net income was $735,893, or $0.03 per diluted share, compared to net income of $1.94m, or $0.07 per diluted share, for the comparable period last year.

NorLevo is to be taken within 72 hours following an unprotected sexual intercourse. Laboratoire HRA Pharma has licensed the development and commercialization rights for NorLevo Tablets to Sosei

Inspra (eplerenone) is a steroid nucleus-based mineralcorticoid receptor (MR) antagonist with a higher degree of selectivity than spironolactone. In the Phase 3B, multinational, randomized, double-blind placebo-controlled, parallel-group trial,

The CHMP has recommended to grant the marketing authorization for Vibativ (telavancin hydrochloride) as a treatment for adults who are suffering from nosocomial pneumonia with ventilator-associated pneumonia, known

The new patent entitled ‘Polyoxazoline and compositions comprising the same,’ covers the synthesis and composition of polyoxazolines for the delivery of different drug molecules. Serina chief scientific officer

SUTENT is an oral multi-kinase inhibitor that works by blocking multiple molecular targets implicated in the growth, proliferation and spread of cancer. The FDA approval is based on

The completed integration is expected to enable the rapid transfer of Phase I data and metadata collected in ALPHADAS into Medidata Rave. ALPHADAS is a multi-study, schedule-driven, automated

The CHMP has recommended the marketing authorization of Benlysta as an add-on therapy in adult patients who are suffering from active autoantibody-positive systemic lupus erythematosus, with a high